ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+5.35%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$235M
AUM Growth
+$235M
(+24%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
46.57%
Holding
91
New
39
Increased
11
Reduced
15
Closed
22
Top Buys
| 1 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$12.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11.5M |
| 3 |
Gilead Sciences
GILD
|
$10.1M |
| 4 |
Takeda Pharmaceutical
TAK
|
$8.91M |
| 5 |
Icon
ICLR
|
$8.16M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$14.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.8M |
| 3 |
SHPG
Shire pic
SHPG
|
$8.02M |
| 4 |
CVS Health
CVS
|
$7.36M |
| 5 |
DaVita
DVA
|
$7.24M |
Sector Composition
| 1 | Healthcare | 79.87% |
| 2 | Technology | 11.14% |
| 3 | Industrials | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $13.9M | 5.49% | 291,281 +241,944 | +490% | +$11.5M |
|
|
IIN
2
DELISTED
IntriCon Corporation
IIN
| $13.9M | 5.48% | 552,457 +304,477 | +123% | +$7.64M |
|
|
3
Icon
ICLR
$13.8B
| $13.8M | 5.45% | 100,874 +59,742 | +145% | +$8.16M |
|
|
VCRA
4
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $12.4M | 4.89% | +390,887 | New | +$12.4M |
|
5
Cigna
CI
$80.3B
| $10.8M | 4.26% | 66,997 -3,947 | -6% | -$635K |
|
|
6
Gilead Sciences
GILD
$140B
| $10.1M | 4% | +155,793 | New | +$10.1M |
|
7
Zimmer Biomet
ZBH
$21B
| $9.87M | 3.9% | 77,286 -46,619 | -38% | -$5.95M |
|
|
8
Takeda Pharmaceutical
TAK
$47.3B
| $8.91M | 3.52% | +437,436 | New | +$8.91M |
|
9
HCA Healthcare
HCA
$94.5B
| $7.83M | 3.1% | +60,075 | New | +$7.83M |
|
|
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
| $7.78M | 3.08% | 247,417 -34,691 | -12% | -$1.09M |
|
|
RCM
11
DELISTED
R1 RCM Inc. Common Stock
RCM
| $7.26M | 2.87% | 750,376 -143,045 | -16% | -$1.38M |
|
12
AtriCure
ATRC
$1.84B
| $7.14M | 2.82% | +266,577 | New | +$7.14M |
|
13
Cencora
COR
$56.5B
| $7.04M | 2.78% | 88,536 +80,196 | +962% | +$6.38M |
|
14
Labcorp
LH
$23.1B
| $6.86M | 2.71% | +44,869 | New | +$6.86M |
|
|
AVDR
15
DELISTED
Avedro, Inc Common Stock
AVDR
| $5.42M | 2.14% | +441,989 | New | +$5.42M |
|
16
Evolent Health
EVH
$1.12B
| $5.27M | 2.08% | +418,728 | New | +$5.27M |
|
17
LivaNova
LIVN
$3.08B
| $4.12M | 1.63% | +42,312 | New | +$4.12M |
|
18
iRhythm Technologies
IRTC
$5.46B
| $3.77M | 1.49% | 50,333 +32,315 | +179% | +$2.42M |
|
19
Tenet Healthcare
THC
$16.3B
| $3.51M | 1.39% | +121,823 | New | +$3.51M |
|
20
Aclaris Therapeutics
ACRS
$209M
| $3.27M | 1.29% | +545,729 | New | +$3.27M |
|
21
Medtronic
MDT
$119B
| $3.24M | 1.28% | 35,579 -57,248 | -62% | -$5.21M |
|
22
Centene
CNC
$14.3B
| $2.92M | 1.15% | +54,995 | New | +$2.92M |
|
23
Thermo Fisher Scientific
TMO
$186B
| $2.87M | 1.14% | +10,500 | New | +$2.87M |
|
24
Ocular Therapeutix
OCUL
$2.12B
| $2.84M | 1.12% | 716,124 +483,397 | +208% | +$1.92M |
|
|
LMNX
25
DELISTED
Luminex Corp
LMNX
| $2.79M | 1.1% | +121,017 | New | +$2.79M |
|